Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Monoclonal Antibody

Anti-HBV HBeAg Monoclonal Antibody (1A240)

Catalog #:   MVV23602 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG
Applications: ELISA, CLIA, ICA, IFA
Overview

Catalog No.

MVV23602

Species reactivity

Hepatitis B virus (HBV)

Host species

Mouse

Isotype

IgG

Clonality

Monoclonal

Immunogen

HBV HBeAg Protein.

Target

External core antigen, HBeAg, Precore protein, p25, C

Concentration

1mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

ELISA, CLIA, ICA, IFA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

1A240

Data Image
References

Precore G1896A mutation of hepatitis B virus in patients with chronic hepatitis B, hepatic cirrhosis, and hepatocellular carcinoma in Burkina Faso., PMID:40493277

High HBsAg Clearance Rate and Viral Dynamics in HBeAg-Positive, ALT-Normal Children and Adolescents with Chronic HBV Infection: Results from the Prospective Sprout Project., PMID:40469009

Prevalence of hepatitis B and C virus infections among Buddhist tribes of Kaza health block, Lahaul and Spiti district of Himachal Pradesh., PMID:40390355

Characteristics of hepatitis B virus surface protein and occult hepatitis B infection in infants with immunoprophylaxis failure from Indonesia., PMID:40305978

Predictors of durable HBsAg loss after pegylated interferon-based therapy in HBeAg-negative CHB patients: a multicenter real-world study., PMID:40272911

Inhibition of HBV Replication by a Fully Humanized Neutralizing Antibody In Vivo and In Vitro., PMID:40264583

Long-term effectiveness of vaccination for prevention of hepatitis B virus mother-to-child transmission in Yunnan, China., PMID:40222091

HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases., PMID:40174727

Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B., PMID:40008890

Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection., PMID:39995381

Virological and serological outcomes in people with HIV-HBV coinfection who had discontinued tenofovir-containing antiretroviral therapy: Results from a prospective cohort study., PMID:39981332

Seroprevalence and associated risk factors of HBV and HCV infections in the population of Ghudduwah Village, South Libya., PMID:39977475

Hepatitis Delta and Liver Disease Among People Living With Hepatitis B With or Without HIV Co-Infection in Senegal., PMID:39967446

Production and characterization of monoclonal antibodies against hepatitis B e-antigen and their potential application for development of HBeAg detection ELISA., PMID:39892062

Economic evaluation of tenofovir disoproxil fumarate prophylaxis to prevent mother-to-child transmission of Hepatitis B virus infection: evidence from a lower-middle income country., PMID:39732705

Rheumatoid factor levels indicate cryoglobulinemia severity in hepatitis B e antigen-negative hepatitis B virus carriers: a 7-year prospective cohort study., PMID:39699792

Misuse of the Lower Limit of Detection in HBV DNA Testing and Anti-HBe Positive Status Will Significantly Impact the Diagnosis of Occult HBV Infection., PMID:39673691

Determinants of mother-to-child transmission of hepatitis B virus among pregnant women in southwestern Nigeria., PMID:39629313

Monocyte-derived Galectin-9 and PD-L1 differentially impair adaptive and innate immune response in chronic HBV infection and their expression remain unaltered after antiviral therapy., PMID:39445017

Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative Hepatitis B Patients., PMID:39425534

VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study., PMID:39389081

CD40 stimulation activates CD8+ T cells and controls HBV in CD4-depleted mice., PMID:39282227

Correlates of Hepatitis B infection in pregnant women attending antenatal clinics in Wa Municipality, Ghana., PMID:39255265

Investigation of Mother-to-Child Transmission of Hepatitis B in Yinchuan, China: Cross-Sectional Survey Study., PMID:39230944

Association of HLA-DRB1 alleles with status of antibodies to hepatitis B surface and e antigen., PMID:39169719

Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis., PMID:39066283

Effect of hepatitis B vaccination on HBV-infection among school children in Yaounde; ten years after the introduction of HBV vaccine into routine Immunization Program in Cameroon., PMID:39036018

Seroepidemiology of hepatitis B virus (HBV) and relationship to serum transaminase levels in Indian population., PMID:39027877

Prevalence of HBV genotypes among patients attending Moi Teaching and Referral Hospital liver clinic., PMID:38985789

A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally suppressed patients with chronic hepatitis B who are HBeAg-negative., PMID:38976867

A Case of Intravenous IVIg Interfering with Serological Test Results of HBV., PMID:38965960

High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo., PMID:38959256

Occurrence of hepatitis B and C virus infection in socioeconomic population strata from Recife, Pernambuco, Northeast Brazil., PMID:38958369

The prevalence of hepatitis B virus infection among HIV-infected patients in the Ningxia Hui Autonomous Region, China, November 2002 to July 2023., PMID:38954861

Clinical and virological characteristics of coexistent hepatitis B surface antigen and antibody in treatment-naive children with chronic hepatitis B virus infection., PMID:38952725

Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon., PMID:38900729

Serological profile of hepatitis B virus infection among traditional birth attendants and the attending pregnant women in Ibadan, Nigeria., PMID:38755959

Quantitative hepatitis B core antibody and quantitative hepatitis B surface antigen: Novel viral biomarkers for chronic hepatitis B management., PMID:38689745

Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy., PMID:38570803

Early application of IFNγ mediated the persistence of HBV in an HBV mouse model., PMID:38556058

mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model., PMID:38543871

In Vitro Lactic Acid Bacteria Anti-Hepatitis B Virus (HBV) Effect and Modulation of the Intestinal Microbiota in Fecal Cultures from HBV-Associated Hepatocellular Carcinoma Patients., PMID:38474727

Analysis of Serum Anti-HBs Levels and HBsAg/HBeAg Markers in Children and Adolescents: A Cross-Sectional Study., PMID:38447125

Characteristics of Hepatitis B Virus, Hepatitis C Virus, and Syphilis Coinfection in People With HIV/AIDS Contracted Through Different Sources: Retrospective Study., PMID:38412004

Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg., PMID:38378606

Breakthrough infection by hepatitis B virus in a vaccinated blood donor: An emerging threat for transfusion safety in low-endemic countries?, PMID:38345135

Hepatitis B in Trans-Himalayan Tribal Population: High Prevalence, High Pediatric Burden, Virologic Patterns, and Implications for Public Health Interventions., PMID:38283704

Protection level of anti-hepatitis B vaccine and immunoglobulin in a pediatric Cameroonian population., PMID:38204806

Epidemiological and clinical profile of pediatric hepatitis B virus infections in Wuhan: a retrospective cohort study., PMID:38104124

SEROEPIDEMIOLOGY OF HBV ANTIGEN AND ANTI-HCV AMONG GENERAL POPULATION IN A RURAL LOCAL IN BAUCHI STATE, NIGERIA., PMID:38070129

Datasheet
$ 196
Product specifications
50 μg 196 100 μg 313

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-HBV HBeAg Monoclonal Antibody (1A240) [MVV23602]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only